Related Experiment Video
Updated: May 16, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
[Role of antithrombin iii in cardiac surgery]
V Muedra1, D Barettino, P D'Ocón
1Departamento de Anestesiología-Reanimación y Terapéutica del Dolor, Hospital Universitario La Ribera, Alzira, Valencia, España.
Insights
Cardiac surgery disrupts blood coagulation. Lowered antithrombin III activity correlates with worse outcomes, suggesting supplementation may improve patient recovery and reduce risks.
Area of Science:
- Multidisciplinary scientific interest in blood coagulation.
- Focus on hemostasis and its clinical implications.
Context:
- Cardiac surgery significantly alters the balance of pro-coagulant and anti-coagulant factors.
- Postoperative complications are a major concern in cardiac surgery patients.
Purpose:
- To analyze the role of antithrombin III in the context of cardiac surgery.
- To investigate the association between antithrombin III activity and postoperative outcomes.
Summary:
- Decreased antithrombin III activity levels were found to be associated with increased postoperative morbidity and mortality.
- Exogenous antithrombin III supplementation is being considered to optimize patient outcomes.
Impact:
- Antithrombin III's anticoagulant and anti-inflammatory properties are gaining attention.
- Findings suggest new research avenues for improving cardiac surgery patient care and outcomes.
Abstract:
Coagulation of blood is of multidisciplinary interest. Cardiac surgery produces major changes in the delicate balance between pro-and anti-coagulant serum factors. The role of antithrombin iii has been analysed after finding evidence that associated decreased levels of protein activity to postoperative morbidity and mortality. Supplementing exogenous antithrombin is considered with the aim of optimising outcomes. Its intrinsic anticoagulant and anti-inflammatory properties have stimulated a growing interest, and suggests new lines of research.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Mitral Stenosis III: Medical Management
Cardiac Catheterization III: Left Heart Catheterization
Endocarditis III: Medical Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
